Cocaine Use Disorder Clinical Trial
— RVCOCOfficial title:
Development and Evaluation of a Virtual Reality Application for Eliciting Craving and Its Physiological Arousal in Cocaine Users
Verified date | September 2022 |
Source | Laboratoire de Psychologie des Cognitions |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Our study main objective is to test whether virtual reality exposure could elicit cocaine craving and its physiological arousal in cocaine users. Investigators aim to compare self-reported cocaine craving, self-efficacy to cope with craving and emotional states levels in 11 voluntary and adults cocaine users in 3 consecutive 10-mins conditions: Neutral VR (virtual reality exposure to neutral stimuli), Cocaine VR (virtual reality exposure to cocaine use-related stimuli) and Relaxation (respiratory relaxation).
Status | Completed |
Enrollment | 11 |
Est. completion date | July 29, 2021 |
Est. primary completion date | July 29, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Cocaine use within the past 28 days Exclusion Criteria: - Actual manic or hypomanic episode (MINI, Lecrubier and al., 1998) - Actual psychotic episode (MINI, Lecrubier and al., 1998) - Actual high suicidal risk (MINI, Lecrubier and al., 1998) - Being involved in incarceration procedure - Medical risk for safety while physiological arousal (e.g. cardiac disease) - Disability for performing virtual reality task (e.g. blindness or deafness) - Significant motion sickness symptoms (SSQ pre-post total score = 15, Bimberg et al., 2020) |
Country | Name | City | State |
---|---|---|---|
France | Laboratoire de Psychologie des Cognitions (Strasbourg University) | Strasbourg | Bas-Rhin |
Lead Sponsor | Collaborator |
---|---|
Laboratoire de Psychologie des Cognitions | ICube Laboratory - Team IGG, Ithaque Association, The French Institute for Public Health Research, The French National Cancer Institute, University Hospital, Strasbourg, France, University Hospitals of Strasbourg |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cocaine Craving Intensity | Change in self-reported cocaine craving intensity between 3 consecutive interventions: Neutral VR, Cocaine VR and Relaxation (CCQ-Brief total score, french version; Karila and al., 2011). CCQ-Brief total score varies from 10 to 70 (higher score suggesting higher craving intensity). | Immediatly after Neutral VR, Cocaine VR and Relaxation (10 mins between each measure) | |
Secondary | Self-Efficacy to Cope with Cocaine Craving without Using | Change in self-reported efficacy level to cope with cocaine craving without using between 3 consecutive interventions: Neutral VR, Cocaine VR and Relaxation (DTCQ-8 total score, original version translated in french; Sklar and Turner, 1999). DTCQ-8 total score varies from 0 to 800 (higher score suggesting higher self-efficacy to cope with cocaine craving without using). | Immediatly after Neutral VR, Cocaine VR and Relaxation (10 mins between each measure) | |
Secondary | Negative Emotional States | Change in negative emotional states level between 3 consecutive interventions: Neutral VR, Cocaine VR and Relaxation (BMIS negative emotional states total score, adapted version translated in french Mayer et al., 1988). BMIS negative emotional states total score varies from 0 to 21 (higher score suggesting higher negative emotional states). | Immediatly after Neutral VR, Cocaine VR and Relaxation (10 mins between each measure) | |
Secondary | Positive Emotional States | Change in positive emotinal states level between 3 consecutive interventions: Neutral VR, Cocaine VR and Relaxation (BMIS positive emotional states total score, adapted version translated in french Mayer et al., 1988). BMIS positive emotional states total score varies from 0 to 9 (higher score suggesting higher positive emotional states). | Immediatly after Neutral VR, Cocaine VR and Relaxation (10 mins between each measure) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03538548 -
Treatment Outcome in CBT for Cocaine Use
|
N/A | |
Recruiting |
NCT04994821 -
tDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study
|
Phase 2 | |
Not yet recruiting |
NCT06050304 -
CRACK-TARGET 1: ÉTUDE DESCRIPTIVE DE LA SENSIBILISATION COMPORTEMENTALE OBSERVÉE et ATTENTES
|
||
Completed |
NCT02233647 -
Phendimetrazine and Cocaine
|
Early Phase 1 | |
Completed |
NCT02239913 -
Topiramate-Phentermine Combinations for Cocaine Dependence
|
Phase 1 | |
Not yet recruiting |
NCT05974202 -
rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder
|
Phase 2 | |
Recruiting |
NCT04927143 -
Encouraging Abstinence Behavior in a Drug Epidemic
|
Phase 2 | |
Completed |
NCT03224546 -
Cocaine Use Reduction and Health
|
N/A | |
Recruiting |
NCT03656653 -
Imagery-based Coping for Cocaine Use Disorder
|
N/A | |
Completed |
NCT03348384 -
[11C]NOP-1A and Cocaine Use Disorders
|
Early Phase 1 | |
Recruiting |
NCT05019430 -
Cocaine and Zolmitriptan
|
Early Phase 1 | |
Recruiting |
NCT03344419 -
Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders
|
Phase 3 | |
Recruiting |
NCT05507814 -
Temporal Window and Episodic Future Thinking in CUD
|
N/A | |
Active, not recruiting |
NCT03799341 -
Neurocognitive Factors in Substance Use Treatment Response: The Ways of Rewarding Abstinence Project
|
N/A | |
Completed |
NCT02785406 -
Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use
|
Phase 2 | |
Completed |
NCT02798627 -
Trial Of NS2359 For The Treatment of Cocaine Dependence
|
Phase 2 | |
Completed |
NCT02444208 -
A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use
|
N/A | |
Recruiting |
NCT05902819 -
Reconsolidation Blockade of Intrusive Trauma- and Cocaine-related Memories
|
N/A | |
Recruiting |
NCT05833529 -
Innovative Cognitive and Behavioral Psychotherapy for Cocaine Use Disorder
|
N/A | |
Recruiting |
NCT05521854 -
Contingency Management for Drug Use: Does Age Matter?
|
N/A |